14th International HIV Drug Resistance Workshop (14th IHDRW), 7-11 June 2005, Quebec City, Canada
15 July 2005. Related: Conference reports.
Intl Drug Resistance Workshop 14 Quebec 2005
Genetic factors affecting HIV infection and progression rates: immunological factors relating to entry inhibitors
15 July 2005. Related: Conference reports, Basic science and immunology.
Resistance during MTCT strategies: new data on protective benefit of Combivir added to single-dose nevirapine, and impact of treatment and breastfeeding on the infant
15 July 2005. Related: Conference reports, Pregnancy.
Reduced replicative capacity of M184V explains benefit of 3TC monotherapy compared to stopping all drugs
14 July 2005. Related: Conference reports, Antiretrovirals.
Interaction between tenofovir and ddI in triple-nucleoside combinations: role of M184V in explaining resistance on failure
14 July 2005. Related: Conference reports, Resistance.
Predicting clinical responses to ddI from genotypic resistance
14 July 2005. Related: Conference reports, Resistance.
Under-detection of transmission of transmitted resistance and impact on treatment response
14 July 2005. Related: Conference reports, Resistance.
Risk of death in UK after diagnosis of 3-class resistance
14 July 2005. Related: Conference reports, Resistance.
